Protective effect of intracerebroventricularly administered PGE2 on rat gastric mucosa.
D000818:Animals; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D015232:Dinoprostone; D005260:Female; D005753:Gastric Mucosa / Q000187:drug effects*; D006851:Hydrochloric Acid / Q000494:pharmacology; D007276:Injections, Intraventricular; D007279:Injections, Subcutaneous; D011458:Prostaglandins E / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D011919:Rats, Inbred Strains; D012972:Sodium Hydroxide / Q000494:pharmacology
D000897:Anti-Ulcer Agents; D011458:Prostaglandins E; D012972:Sodium Hydroxide; D015232:Dinoprostone; D006851:Hydrochloric Acid